TCL Archive New benchmark for CCSG award funding will be lowered from 20 percent of NCI research base to 15 percent, the program’s “reality ratio,” Karen Antman tells NCAB. October 8, 2004
TCL Archive FDA Committee Okays High Dose Methotrexate, Mitxantrone In ANL; reverse Breast Cancer Vote December 11, 1987
TCL Archive “A significant reduction in the NCI IRP AIDS program may be in order, and released funds should … increase the pool available to extramural research.” July 21, 1995
TCL Archive In Brief: Peter Vogt Names Bristol-Myers Winner; Other Awards: Koop, Weinberg, Wynder, Longmire March 24, 1989
